scholarly journals Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients

2016 ◽  
Vol 101 (5) ◽  
pp. 2122-2129 ◽  
Author(s):  
Jennifer S. ten Kulve ◽  
Liselotte van Bloemendaal ◽  
Rawien Balesar ◽  
Richard G. IJzerman ◽  
Dick F. Swaab ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Receptor Expression ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1 ◽  
Diabetes Patients

scholarly journals Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries

2014 ◽  
Vol 5 (2) ◽  
pp. 499-520 ◽  
Author(s):  
Victoria Divino ◽  
Mitch DeKoven ◽  
Shawn Hallinan ◽  
Nebibe Varol ◽  
Sara Bruce Wirta ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Receptor Agonist ◽  
Treatment Patterns ◽  
European Countries ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1 ◽  
Diabetes Patients

scholarly journals Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

PLoS ONE ◽  
2012 ◽  
Vol 7 (12) ◽  
pp. e50117 ◽  
Author(s):  
Daniel J. Cuthbertson ◽  
Andrew Irwin ◽  
Chris J. Gardner ◽  
Christina Daousi ◽  
Tej Purewal ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Liver Fat ◽  
Receptor Agonists ◽  
Fat Reduction ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1 ◽  
Diabetes Patients
Sign in / Sign up

Export Citation Format

Share Document